Phreesia Q2 GAAP EPS of -$0.89 beats by $0.08

Trending News 🌥️

Phreesia($NYSE:PHR), Inc announced its second quarter results today, posting a GAAP EPS of -$0.89, which beat analyst expectations by $0.08. Revenue came in at $67.9 million, also beating expectations by $2.15 million. This positive news may have a positive effect on Phreesia’s market share and earnings in the long term. However, it is worth noting that the company posted a GAAP EPS loss in the second quarter, so investors will be closely watching to see if Phreesia can maintain its positive momentum in the coming quarters.

Market Price

On Wednesday, PHREESIA stock opened at $22.6 and closed at $23.9, rise by 5.1% from prior closing price of 22.8. This was the company’s first quarterly GAAP EPS beat in the past four quarters.

VI Analysis

A company’s fundamentals reflect its long term potential. The VI app makes it easy to analyze a company’s financials and business risk. Based on the VI Risk Rating, PHREESIA is a medium risk investment. Financial risks include the potential for negative cash flow and high debt levels. Business risks include the potential for negative publicity and regulatory scrutiny.

Summary

This news drove the stock price up on the same day. Investing in Phreesia may be a good idea for investors who are looking for a healthcare technology company that is growing quickly and beating earnings expectations. The company’s strong second quarter results show that it is on track to continue its growth trajectory. Phreesia provides an integrated platform that helps healthcare organizations manage the patient intake process. Healthcare organizations are under increasing pressure to improve the patient experience and reduce costs. Phreesia’s platform helps them do both by streamlining the patient intake process. This is a valuable solution for healthcare organizations, and Phreesia is well-positioned to continue growing its business.